Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 2 Interventional

A Study to Evaluate the Safety and Efficacy of Omiganan (CLS001) Topical Gel Versus Vehicle in Female Subjects With Moderate to Severe Acne Vulgaris

ClinicalTrials.gov ID: NCT02571998

Public ClinicalTrials.gov record NCT02571998. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 22, 2026, 4:41 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Phase 2, Randomized, Double-Blind, Vehicle-Controlled, Parallel Group Multicenter Study to Evaluate the Safety and Efficacy of CLS001 Topical Gel Versus Vehicle Applied Once Daily for 12 Weeks to Female Subjects With Moderate to Severe Acne Vulgaris

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

The primary objective of this study is to evaluate the safety and efficacy of Omiganan (CLS001) topical gel compared to vehicle topical gel applied once daily for 12 weeks in female subjects with moderate to severe inflammatory acne vulgaris.

Study identification

NCT ID
NCT02571998
Recruitment status
Completed
Study type
Interventional
Phase
Phase 2
Lead sponsor
Maruho Co., Ltd.
Industry
Enrollment
320 participants

Conditions and interventions

Eligibility (public fields only)

Age range
12 Years and older
Sex
Female
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Oct 2015 (Type not available)
Primary completion
Aug 2016 (Actual)
Completion
Aug 2016 (Actual)
Last update posted
Mar 27, 2017

2015 – 2016

United States locations

U.S. sites
29
U.S. states
17
U.S. cities
29
Facility City State ZIP Site status
Not listed Mobile Alabama — —
Not listed Phoenix Arizona — —
Not listed Santa Ana California — —
Not listed Santa Monica California — —
Not listed Denver Colorado — —
Not listed Boca Raton Florida — —
Not listed Boynton Beach Florida — —
Not listed Miami Florida — —
Not listed Pinellas Park Florida — —
Not listed Sanford Florida — —
Not listed Tampa Florida — —
Not listed Beverly Massachusetts — —
Not listed Fort Gratiot Michigan — —
Not listed St Louis Missouri — —
Not listed Las Vegas Nevada — —
Not listed Newington New Hampshire — —
Not listed Albuquerque New Mexico — —
Not listed New York New York — —
Not listed Stony Brook New York — —
Not listed High Point North Carolina — —
Not listed Raleigh North Carolina — —
Not listed Knoxville Tennessee — —
Not listed Arlington Texas — —
Not listed Austin Texas — —
Not listed Pflugerville Texas — —
Not listed San Antonio Texas — —
Not listed Webster Texas — —
Not listed Salt Lake City Utah — —
Not listed Spokane Washington — —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT02571998, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Mar 27, 2017 · Synced Oct 22, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT02571998 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →